Can You Split a Mounjaro Pen Dose? What U.S. Instructions Say

Can you split a Mounjaro pen into smaller doses?

The U.S. instructions describe fixed-dose Mounjaro devices, not a pen-click method for measuring a fraction of a dose. The single-dose pen is used once for its labeled weekly dose. The multi-dose KwikPen contains four fixed weekly doses; its instructions say to turn the dose knob until it stops and the dose icon appears in the window. They do not give a click-to-milligram conversion or a partial-dose procedure.

The instructions also say not to inject leftover medicine after the fourth KwikPen dose and not to transfer medicine from the pen into a syringe. A click chart therefore cannot be used as an FDA-labeled way to divide a Mounjaro pen dose.

What the U.S. instructions say about each format

Format	How the official instructions describe the dose
Single-dose prefilled pen	One pen is used once for its labeled weekly dose. The instructions do not describe partial doses or measuring doses by clicks.
KwikPen	Four fixed weekly doses per pen. For each dose, the instructions specify turning the knob until it stops and the dose icon appears in the window.
Vial	The vial instructions specify the labeled volume for one weekly injection. This is a different presentation from withdrawing medicine from a pen.

Why click charts do not establish a Mounjaro dose

The current FDA-approved Mounjaro instructions identify the dose by the device’s labeled dose indicator or by the vial instructions. They provide no validated conversion from clicks to a fraction of the labeled dose. The KwikPen’s two clicks used to reach its priming position are part of the priming steps, not a dose chart.

Primary source

• FDA-approved Mounjaro prescribing information and Instructions for Use, revised 2026 (see Instructions for Use for the single-dose pen, KwikPen, and vials).

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. KwikPen is a registered trademark of Eli Lilly. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly.

Related guides

• How to Split a Zepbound Dose: Chart, Mechanics, and What Your Provider Needs to Know
• Can You Split Your Tirzepatide Dose? What the Pharmacology Says and When Splitting Makes Clinical Sense
• Splitting Your Tirzepatide Dose: Why Some Patients Do It, the Half-Life Math, and How to Do It Safely
• Accidentally Took a Double Dose of Mounjaro: What Happens, What to Do, and When to Get Help
• Accidentally Took a Double Dose of Mounjaro? What to Do, What to Watch For, and When to Call for Help
• How Many Clicks in an 8 mg Ozempic Pen? A Precise Dose Chart and Safety Guide
• Tool: dosage calculator